ArticleThoracic cancer2022

Neoadjuvant PD-1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung.

Yuan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.